Evidence map›Paper›PMID 30401779›Full record

ArticlemBio2018

Gut Microbial and Metabolic Responses to Salmonella enterica Serovar Typhimurium and Candida albicans.

Jennifer R Bratburd, Caitlin Keller, Eugenio Vivas, Erin Gemperline, Lingjun Li, Federico E Rey, Cameron R Currie

Open access · goldAbstract read
In one paragraph

Article in mBio, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. LowFrontiers in microbiology · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jennifer R Bratburd *Department of Bacteriology, University of Wisconsin, Madison, Wisconsin, USA.
Caitlin Keller *Department of Chemistry, University of Wisconsin, Madison, Wisconsin, USA.
Eugenio VivasDepartment of Bacteriology, University of Wisconsin, Madison, Wisconsin, USA.
Erin GemperlineDepartment of Chemistry, University of Wisconsin, Madison, Wisconsin, USA.
Lingjun LiDepartment of Chemistry, University of Wisconsin, Madison, Wisconsin, USA lingjun.li@wisc.edu ferey@wisc.edu currie@bact.wisc.edu.
Federico E ReyDepartment of Bacteriology, University of Wisconsin, Madison, Wisconsin, USA lingjun.li@wisc.edu ferey@wisc.edu currie@bact.wisc.edu.
Cameron R CurrieDepartment of Bacteriology, University of Wisconsin, Madison, Wisconsin, USA lingjun.li@wisc.edu ferey@wisc.edu currie@bact.wisc.edu.
University of Wisconsin–Madison · US

Funding

Metabolomics driven discovery of drug leads from symbiotic bacteriaU19AI109673 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI ANDES, DAVID R, CURRIE, CAMERON ROBERT · 2014 to 2018
$16.2M
Mass Spectrometric Studies of Neuropeptides in FeedingR01DK071801 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI LINGJUN LI · 2006 to 2026
$6.7M
Microbial Pathogenesis &Host Responses Training ProgramT32AI055397 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI KLEIN, BRUCE STEVEN · 2003 to 2024
$5.5M
Collaborative Cross of the Microbiome and Metabolic DiseaseR01DK108259 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI REY, FEDERICO E · 2015 to 2019
$2.1M
Acquisition of a High-Field Dual Source FTICR-MS for Pharmaceutical ResearchS10RR029531 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI LI, LINGJUN · 2011 to 2011
$2.1M
Mass Spectrometric Studies of Neuropeptides in FeedingR56DK071801 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI LI, LINGJUN · 2011 to 2011
$216k
NCRR NIH HHS S10 RR029531NIAID NIH HHS T32 AI055397NIAID NIH HHS U19 AI109673NIDDK NIH HHS R01 DK071801NIDDK NIH HHS R01 DK108259NIDDK NIH HHS R56 DK071801
6 · The paper itself

Abstract

The gut microbiota confers resistance to pathogens of the intestinal ecosystem, yet the dynamics of pathogen-microbiome interactions and the metabolites involved in this process remain largely unknown. Here, we use gnotobiotic mice infected with the virulent pathogen

Indexed as

Gastrointestinal MicrobiomeMicrobiotaAnimalsBiosynthetic PathwaysCandida albicansCandidiasisCecumDisease Models, AnimalEnterobacteriaceaeGerm-Free LifeHumansMaleMetabolomicsMetagenomicsMiceMice, Inbred C57BLgut microbiomemetabolomicsmetagenomicsSalmonella

Identifiers

PMID30401779
PMCPMC6222126
OpenAlexW2899704524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.